Kjell Erik Julius Håkansson

Medicin og biovidenskab

1. Asthma 100%
2. Adrenal Cortex Hormones 50%
3. Cohort Studies 47%
4. Hydroxychloroquine 38%
5. Chronic Obstructive Pulmonary Disease 37%
6. Bronchiectasis 24%
7. Mortality 24%
8. Azithromycin 23%
9. Young Adult 23%
10. Coronavirus 22%
11. Hydroxymethylglutaryl-CoA Reductase Inhibitors 18%
12. Antidepressive Agents 17%
13. Outpatients 14%
14. Urokinase Plasminogen Activator Receptors 13%
15. Absenteeism 12%
16. Severe Acute Respiratory Syndrome 11%
17. Eosinophils 11%
18. Patient Readmission 11%
19. Interleukin-5 10%
20. Social Class 10%
21. Drive 9%
22. Income 9%
23. Randomized Controlled Trials 9%
24. Biological Products 9%
25. Hospital Mortality 9%
26. Depression 9%
27. Hospitalization 9%
28. Meta-Analysis 8%
29. Denmark 8%
30. 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole 7%
31. Rheumatoid Arthritis 7%
32. Placebos 7%
33. Delivery of Health Care 7%
34. Inflammation 7%
35. Systematic Reviews 7%
36. Referral and Consultation 7%
37. Anxiety 6%
38. Prospective Studies 6%
39. Education 6%
40. Mood Disorders 6%
41. Quality of Life 6%
42. Prescriptions 6%
43. Costs and Cost Analysis 5%
44. Cardiovascular Diseases 5%
45. Infections 5%
46. Child 5%